C07D 313/06
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D313/06 (Condensed with carbocyclic rings or ring systems) appears on 474 US grants and 265 published applications in this corpus.
Search patents in C07D- Granted patents
- 474
- Published applications
- 265
- Assignees
- 218
- Inventors
- 1,093
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 9 | 0 |
| 1978 | 63 | 0 |
| 1979 | 14 | 0 |
| 1980 | 10 | 0 |
| 1981 | 9 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 9 | 0 |
| 1986 | 7 | 0 |
| 1987 | 6 | 0 |
| 1988 | 4 | 0 |
| 1989 | 14 | 0 |
| 1990 | 8 | 0 |
| 1991 | 12 | 0 |
| 1992 | 9 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 10 | 0 |
| 1999 | 8 | 0 |
| 2000 | 11 | 0 |
| 2001 | 15 | 5 |
| 2002 | 15 | 9 |
| 2003 | 11 | 13 |
| 2004 | 8 | 9 |
| 2005 | 7 | 10 |
| 2006 | 7 | 13 |
| 2007 | 7 | 10 |
| 2008 | 11 | 9 |
| 2009 | 4 | 15 |
| 2010 | 12 | 14 |
| 2011 | 11 | 15 |
| 2012 | 9 | 12 |
| 2013 | 10 | 12 |
| 2014 | 9 | 9 |
| 2015 | 11 | 12 |
| 2016 | 5 | 12 |
| 2017 | 11 | 7 |
| 2018 | 5 | 9 |
| 2019 | 8 | 10 |
| 2020 | 3 | 6 |
| 2021 | 8 | 7 |
| 2022 | 5 | 7 |
| 2023 | 8 | 9 |
| 2024 | 7 | 14 |
| 2025 | 10 | 10 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Enzyme-mediated process for making Amberketal and Amberketal homologues24 Mar 2026US 12,584,153 B2Givaudan SA
- Mitochondrial permeability transition pore (mPTP)-opening inhibitor, novel compound exhibiting mPTP-opening inhibitory activity, and use therefor10 Feb 2026US 12,544,354 B2Riken
- Estrogen receptor-modulating compounds16 Dec 2025US 12,497,386 B2Radius Pharmaceuticals, Inc.
- Monomer, resin for photoresist, resin composition for photoresist, and pattern forming method16 Dec 2025US 12,498,638 B2Daicel Corporation
- Urolithin derivatives and methods of use thereof18 Nov 2025US 12,473,269 B2Vandria SA
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Compounds for the Treatment of Neuromuscular Disorders16 Jul 2026US 2026/0199273 A1Nmd Pharma A/S
- Resist composition, resist pattern formation method, compound, and acid generator9 Jul 2026US 2026/0194811 A1Tokyo Ohka Kogyo.Co., Ltd.
- Aminoindane Compounds and Compositions and Methods of Their Therapeutic Use11 Jun 2026US 2026/0159474 A1Solvonis Therapeutics Ireland Holdings Limited
- Urolithin derivatives and methods of use thereof14 May 2026US 2026/0132117 A1Vandria SA
Most cited
By later US patents
- Tricyclic ethers, their preparation and the pharmaceutical compositions containing them138US 4,496,557 AAdir · 1985
- Synthesis of aryl ethers88US 5,847,166 AMassachusetts Institute of Technology · 1998
- Synthesis of aryl ethers71US 6,166,226 AMassachusetts Institute of Technology · 2000
- Guanidine derivatives66US 6,346,527 B1Fujisawa Pharmaceutical Co., Ltd. · 2002
- Benzofuran and dihydrobenzofuran melatonergic agents65US 5,856,529 ABristol-Myers Squibb Company · 1999